Research Library

The market for stem cell therapies is growing, but most of these treatments are still experimental — and patients who undergo them risk experiencing serious side effects. This quick take offers three recommendations to improve patient safety and education around stem cell interventions in Texas.

Stem cells have two unique properties that make them an appealing therapeutic tool for regenerative medicine: they can grow indefinitely and can differentiate into a wide variety of cell types, including those that form blood, bones, lungs, skin, and the brain.

Input from the public is particularly important when developing science policies that involve controversial and morally complex issues, the authors write.

This journal article explores why the public and stakeholders should help develop guidelines and policies governing scientific practices for controversial biomedical research issues, such as genetically editing human embryos.

In this report, the authors outline the U.S. federal budget process for scientific R&D, discuss trends in federal R&D funding and provide an outlook for federal scientific R&D funding during the Biden administration.

The Covid-19 experience shows that it is time to establish a national surveillance system to manage public health emergencies, the authors write.

This policy report explains how specific tools of economic statecraft can be applied to reduce risks caused by dependence on People’s Republic of China-dominated supply chains for critical goods. It offers foundational building blocks for the formulation and implementation of a larger strategy to reduce American vulnerabilities to China.

The authors examine the investments, trade-offs and broad policy changes necessary to reimagine the U.S. health care delivery system.